Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concerns
Fate Therapeutics Inc FATE
$2.84
▲ +7.98%
(+$0.21)
Open
$2.68
Prev Close
$2.63
Day Range
$2.64 – $2.88
52W Range
$0.91 – $2.88
Market Cap
$331.03M
Beta
2.53
EPS (TTM)
$-1.09
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-10-01 |
| Shares Out. | 116,560,000 |
| Website | fatetherapeutics.com/ ↗ |
| Phone | 13026365400 |
Fate Therapeutics Inc is a publicly traded company under the ticker symbol FATE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-05-01)